Pacira BioSciences Appoints Shawn Cross As CFO
(RTTNews) - Pacira BioSciences, Inc. (PCRX), a company focused on non-opioid pain therapies, said on Monday that it has appointed Shawn Cross as Chief Financial Officer.
Prior to joining Pacira, Cross served at Applied Molecular Transport, Inc., or AMT, a developer of novel oral biological therapeutics to treat severe autoimmune, metabolic, and inflammatory diseases.
He initially served as AMT's CFO. Cross was subsequently promoted to the role of COO and later appointed as CEO to lead the company's merger with Cyclo Therapeutics, Inc. (CYTH), where he currently serves on the Board.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.